nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRS—connective tissue—systemic scleroderma	0.0237	0.118	CbGeAlD
Alendronate—PTPN4—digestive system—systemic scleroderma	0.02	0.0995	CbGeAlD
Alendronate—PTPN4—tendon—systemic scleroderma	0.019	0.0947	CbGeAlD
Alendronate—PTPRE—lung—systemic scleroderma	0.0175	0.0873	CbGeAlD
Alendronate—PTPN4—lung—systemic scleroderma	0.0167	0.0831	CbGeAlD
Alendronate—PTPRS—lung—systemic scleroderma	0.0143	0.0712	CbGeAlD
Alendronate—ATP6V1A—skin of body—systemic scleroderma	0.0123	0.0615	CbGeAlD
Alendronate—FDPS—connective tissue—systemic scleroderma	0.0103	0.0513	CbGeAlD
Alendronate—ATP6V1A—digestive system—systemic scleroderma	0.00986	0.0492	CbGeAlD
Alendronate—FDPS—smooth muscle tissue—systemic scleroderma	0.00941	0.0469	CbGeAlD
Alendronate—ATP6V1A—tendon—systemic scleroderma	0.00939	0.0468	CbGeAlD
Alendronate—FDPS—skin of body—systemic scleroderma	0.00929	0.0463	CbGeAlD
Alendronate—ATP6V1A—lung—systemic scleroderma	0.00824	0.0411	CbGeAlD
Alendronate—FDPS—digestive system—systemic scleroderma	0.00743	0.037	CbGeAlD
Alendronate—FDPS—tendon—systemic scleroderma	0.00707	0.0352	CbGeAlD
Alendronate—FDPS—lung—systemic scleroderma	0.0062	0.0309	CbGeAlD
Alendronate—Malaise—Azathioprine—systemic scleroderma	0.00175	0.0022	CcSEcCtD
Alendronate—Melaena—Methotrexate—systemic scleroderma	0.00175	0.00219	CcSEcCtD
Alendronate—Flatulence—Mycophenolic acid—systemic scleroderma	0.00173	0.00216	CcSEcCtD
Alendronate—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00216	CcSEcCtD
Alendronate—Asthenia—Pentoxifylline—systemic scleroderma	0.00172	0.00215	CcSEcCtD
Alendronate—Erythema multiforme—Lisinopril—systemic scleroderma	0.00171	0.00215	CcSEcCtD
Alendronate—Ill-defined disorder—Leflunomide—systemic scleroderma	0.0017	0.00213	CcSEcCtD
Alendronate—Pruritus—Pentoxifylline—systemic scleroderma	0.0017	0.00212	CcSEcCtD
Alendronate—Anaemia—Leflunomide—systemic scleroderma	0.0017	0.00212	CcSEcCtD
Alendronate—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00169	0.00212	CcSEcCtD
Alendronate—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00169	0.00211	CcSEcCtD
Alendronate—Angioedema—Leflunomide—systemic scleroderma	0.00168	0.0021	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00166	0.00207	CcSEcCtD
Alendronate—Malaise—Leflunomide—systemic scleroderma	0.00166	0.00207	CcSEcCtD
Alendronate—Myalgia—Azathioprine—systemic scleroderma	0.00166	0.00207	CcSEcCtD
Alendronate—Vertigo—Leflunomide—systemic scleroderma	0.00165	0.00207	CcSEcCtD
Alendronate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00164	0.00206	CcSEcCtD
Alendronate—Abdominal pain—Mometasone—systemic scleroderma	0.00164	0.00205	CcSEcCtD
Alendronate—Body temperature increased—Mometasone—systemic scleroderma	0.00164	0.00205	CcSEcCtD
Alendronate—Discomfort—Azathioprine—systemic scleroderma	0.00164	0.00205	CcSEcCtD
Alendronate—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00163	0.00203	CcSEcCtD
Alendronate—Anaemia—Mycophenolic acid—systemic scleroderma	0.00162	0.00203	CcSEcCtD
Alendronate—Alopecia—Lisinopril—systemic scleroderma	0.0016	0.00201	CcSEcCtD
Alendronate—Dyspepsia—Captopril—systemic scleroderma	0.0016	0.002	CcSEcCtD
Alendronate—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.0016	0.002	CcSEcCtD
Alendronate—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00199	CcSEcCtD
Alendronate—Dizziness—Pentoxifylline—systemic scleroderma	0.00159	0.00199	CcSEcCtD
Alendronate—Malaise—Mycophenolic acid—systemic scleroderma	0.00158	0.00198	CcSEcCtD
Alendronate—Erythema—Lisinopril—systemic scleroderma	0.00158	0.00198	CcSEcCtD
Alendronate—Infection—Azathioprine—systemic scleroderma	0.00158	0.00197	CcSEcCtD
Alendronate—Vertigo—Mycophenolic acid—systemic scleroderma	0.00157	0.00197	CcSEcCtD
Alendronate—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00196	CcSEcCtD
Alendronate—Chest pain—Leflunomide—systemic scleroderma	0.00156	0.00196	CcSEcCtD
Alendronate—Myalgia—Leflunomide—systemic scleroderma	0.00156	0.00196	CcSEcCtD
Alendronate—Constipation—Captopril—systemic scleroderma	0.00156	0.00195	CcSEcCtD
Alendronate—Flatulence—Lisinopril—systemic scleroderma	0.00156	0.00195	CcSEcCtD
Alendronate—Dysgeusia—Lisinopril—systemic scleroderma	0.00155	0.00193	CcSEcCtD
Alendronate—Discomfort—Leflunomide—systemic scleroderma	0.00155	0.00193	CcSEcCtD
Alendronate—Vomiting—Pentoxifylline—systemic scleroderma	0.00153	0.00191	CcSEcCtD
Alendronate—Muscle spasms—Lisinopril—systemic scleroderma	0.00152	0.0019	CcSEcCtD
Alendronate—Rash—Pentoxifylline—systemic scleroderma	0.00151	0.00189	CcSEcCtD
Alendronate—Dermatitis—Pentoxifylline—systemic scleroderma	0.00151	0.00189	CcSEcCtD
Alendronate—Headache—Pentoxifylline—systemic scleroderma	0.0015	0.00188	CcSEcCtD
Alendronate—Feeling abnormal—Captopril—systemic scleroderma	0.0015	0.00188	CcSEcCtD
Alendronate—Chest pain—Mycophenolic acid—systemic scleroderma	0.00149	0.00187	CcSEcCtD
Alendronate—Myalgia—Mycophenolic acid—systemic scleroderma	0.00149	0.00187	CcSEcCtD
Alendronate—Infection—Leflunomide—systemic scleroderma	0.00149	0.00186	CcSEcCtD
Alendronate—Gastrointestinal pain—Captopril—systemic scleroderma	0.00149	0.00186	CcSEcCtD
Alendronate—Asthenia—Mometasone—systemic scleroderma	0.00149	0.00186	CcSEcCtD
Alendronate—Photosensitivity—Methotrexate—systemic scleroderma	0.00148	0.00185	CcSEcCtD
Alendronate—Discomfort—Mycophenolic acid—systemic scleroderma	0.00147	0.00184	CcSEcCtD
Alendronate—Pruritus—Mometasone—systemic scleroderma	0.00147	0.00183	CcSEcCtD
Alendronate—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00147	0.00183	CcSEcCtD
Alendronate—Anaemia—Lisinopril—systemic scleroderma	0.00146	0.00183	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00145	0.00181	CcSEcCtD
Alendronate—Angioedema—Lisinopril—systemic scleroderma	0.00144	0.0018	CcSEcCtD
Alendronate—Abdominal pain—Captopril—systemic scleroderma	0.00144	0.0018	CcSEcCtD
Alendronate—Body temperature increased—Captopril—systemic scleroderma	0.00144	0.0018	CcSEcCtD
Alendronate—Dry skin—Prednisone—systemic scleroderma	0.00143	0.00179	CcSEcCtD
Alendronate—Nausea—Pentoxifylline—systemic scleroderma	0.00143	0.00178	CcSEcCtD
Alendronate—Malaise—Lisinopril—systemic scleroderma	0.00142	0.00178	CcSEcCtD
Alendronate—Infection—Mycophenolic acid—systemic scleroderma	0.00142	0.00178	CcSEcCtD
Alendronate—Vertigo—Lisinopril—systemic scleroderma	0.00142	0.00177	CcSEcCtD
Alendronate—Diarrhoea—Mometasone—systemic scleroderma	0.00142	0.00177	CcSEcCtD
Alendronate—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00176	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00137	0.00171	CcSEcCtD
Alendronate—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00171	CcSEcCtD
Alendronate—Abdominal distension—Prednisone—systemic scleroderma	0.00135	0.00169	CcSEcCtD
Alendronate—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00169	CcSEcCtD
Alendronate—Myalgia—Lisinopril—systemic scleroderma	0.00134	0.00168	CcSEcCtD
Alendronate—Chest pain—Lisinopril—systemic scleroderma	0.00134	0.00168	CcSEcCtD
Alendronate—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00166	CcSEcCtD
Alendronate—Discomfort—Lisinopril—systemic scleroderma	0.00133	0.00166	CcSEcCtD
Alendronate—Dyspepsia—Leflunomide—systemic scleroderma	0.00132	0.00165	CcSEcCtD
Alendronate—Vomiting—Mometasone—systemic scleroderma	0.00132	0.00165	CcSEcCtD
Alendronate—Feeling abnormal—Azathioprine—systemic scleroderma	0.00131	0.00164	CcSEcCtD
Alendronate—Rash—Mometasone—systemic scleroderma	0.00131	0.00163	CcSEcCtD
Alendronate—Asthenia—Captopril—systemic scleroderma	0.00131	0.00163	CcSEcCtD
Alendronate—Dermatitis—Mometasone—systemic scleroderma	0.00131	0.00163	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.0013	0.00163	CcSEcCtD
Alendronate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.0013	0.00162	CcSEcCtD
Alendronate—Headache—Mometasone—systemic scleroderma	0.0013	0.00162	CcSEcCtD
Alendronate—Pruritus—Captopril—systemic scleroderma	0.00129	0.00161	CcSEcCtD
Alendronate—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00161	CcSEcCtD
Alendronate—Pain—Leflunomide—systemic scleroderma	0.00128	0.0016	CcSEcCtD
Alendronate—Constipation—Leflunomide—systemic scleroderma	0.00128	0.0016	CcSEcCtD
Alendronate—Infection—Lisinopril—systemic scleroderma	0.00128	0.0016	CcSEcCtD
Alendronate—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00128	0.0016	CcSEcCtD
Alendronate—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00158	CcSEcCtD
Alendronate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00126	0.00158	CcSEcCtD
Alendronate—Body temperature increased—Azathioprine—systemic scleroderma	0.00126	0.00157	CcSEcCtD
Alendronate—Abdominal pain—Azathioprine—systemic scleroderma	0.00126	0.00157	CcSEcCtD
Alendronate—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00156	CcSEcCtD
Alendronate—Diarrhoea—Captopril—systemic scleroderma	0.00125	0.00156	CcSEcCtD
Alendronate—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00155	CcSEcCtD
Alendronate—Feeling abnormal—Leflunomide—systemic scleroderma	0.00124	0.00155	CcSEcCtD
Alendronate—Nausea—Mometasone—systemic scleroderma	0.00123	0.00154	CcSEcCtD
Alendronate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00123	0.00153	CcSEcCtD
Alendronate—Pain—Mycophenolic acid—systemic scleroderma	0.00122	0.00153	CcSEcCtD
Alendronate—Constipation—Mycophenolic acid—systemic scleroderma	0.00122	0.00153	CcSEcCtD
Alendronate—Dizziness—Captopril—systemic scleroderma	0.0012	0.00151	CcSEcCtD
Alendronate—Urticaria—Leflunomide—systemic scleroderma	0.00119	0.00149	CcSEcCtD
Alendronate—Abdominal pain—Leflunomide—systemic scleroderma	0.00119	0.00148	CcSEcCtD
Alendronate—Body temperature increased—Leflunomide—systemic scleroderma	0.00119	0.00148	CcSEcCtD
Alendronate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00118	0.00147	CcSEcCtD
Alendronate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00147	CcSEcCtD
Alendronate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00147	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00117	0.00147	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00117	0.00147	CcSEcCtD
Alendronate—Hypersensitivity—Azathioprine—systemic scleroderma	0.00117	0.00146	CcSEcCtD
Alendronate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00117	0.00146	CcSEcCtD
Alendronate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00146	CcSEcCtD
Alendronate—Vomiting—Captopril—systemic scleroderma	0.00116	0.00145	CcSEcCtD
Alendronate—Rash—Captopril—systemic scleroderma	0.00115	0.00144	CcSEcCtD
Alendronate—Dermatitis—Captopril—systemic scleroderma	0.00115	0.00143	CcSEcCtD
Alendronate—Headache—Captopril—systemic scleroderma	0.00114	0.00143	CcSEcCtD
Alendronate—Dyspepsia—Lisinopril—systemic scleroderma	0.00113	0.00142	CcSEcCtD
Alendronate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00113	0.00141	CcSEcCtD
Alendronate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00113	0.00141	CcSEcCtD
Alendronate—Asthma—Methotrexate—systemic scleroderma	0.00112	0.00141	CcSEcCtD
Alendronate—Infection—Mycophenolate mofetil—systemic scleroderma	0.00112	0.0014	CcSEcCtD
Alendronate—Hypersensitivity—Leflunomide—systemic scleroderma	0.0011	0.00138	CcSEcCtD
Alendronate—Constipation—Lisinopril—systemic scleroderma	0.0011	0.00138	CcSEcCtD
Alendronate—Pain—Lisinopril—systemic scleroderma	0.0011	0.00138	CcSEcCtD
Alendronate—Diarrhoea—Azathioprine—systemic scleroderma	0.00109	0.00136	CcSEcCtD
Alendronate—Haemoglobin—Prednisone—systemic scleroderma	0.00108	0.00135	CcSEcCtD
Alendronate—Nausea—Captopril—systemic scleroderma	0.00108	0.00135	CcSEcCtD
Alendronate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00108	0.00135	CcSEcCtD
Alendronate—Haemorrhage—Prednisone—systemic scleroderma	0.00108	0.00135	CcSEcCtD
Alendronate—Asthenia—Leflunomide—systemic scleroderma	0.00108	0.00135	CcSEcCtD
Alendronate—Feeling abnormal—Lisinopril—systemic scleroderma	0.00106	0.00133	CcSEcCtD
Alendronate—Pruritus—Leflunomide—systemic scleroderma	0.00106	0.00133	CcSEcCtD
Alendronate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00105	0.00132	CcSEcCtD
Alendronate—Dizziness—Azathioprine—systemic scleroderma	0.00105	0.00131	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00129	CcSEcCtD
Alendronate—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00103	0.00128	CcSEcCtD
Alendronate—Asthenia—Mycophenolic acid—systemic scleroderma	0.00103	0.00128	CcSEcCtD
Alendronate—Diarrhoea—Leflunomide—systemic scleroderma	0.00103	0.00128	CcSEcCtD
Alendronate—Urticaria—Lisinopril—systemic scleroderma	0.00102	0.00128	CcSEcCtD
Alendronate—Abdominal pain—Lisinopril—systemic scleroderma	0.00102	0.00127	CcSEcCtD
Alendronate—Body temperature increased—Lisinopril—systemic scleroderma	0.00102	0.00127	CcSEcCtD
Alendronate—Pruritus—Mycophenolic acid—systemic scleroderma	0.00101	0.00127	CcSEcCtD
Alendronate—Vomiting—Azathioprine—systemic scleroderma	0.00101	0.00126	CcSEcCtD
Alendronate—Rash—Azathioprine—systemic scleroderma	0.001	0.00125	CcSEcCtD
Alendronate—Dermatitis—Azathioprine—systemic scleroderma	0.001	0.00125	CcSEcCtD
Alendronate—Headache—Azathioprine—systemic scleroderma	0.000995	0.00124	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000994	0.00124	CcSEcCtD
Alendronate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000994	0.00124	CcSEcCtD
Alendronate—Dizziness—Leflunomide—systemic scleroderma	0.000992	0.00124	CcSEcCtD
Alendronate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000979	0.00122	CcSEcCtD
Alendronate—Stomatitis—Methotrexate—systemic scleroderma	0.000978	0.00122	CcSEcCtD
Alendronate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000966	0.00121	CcSEcCtD
Alendronate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000966	0.00121	CcSEcCtD
Alendronate—Vomiting—Leflunomide—systemic scleroderma	0.000954	0.00119	CcSEcCtD
Alendronate—Alopecia—Prednisone—systemic scleroderma	0.000952	0.00119	CcSEcCtD
Alendronate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000949	0.00119	CcSEcCtD
Alendronate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000946	0.00118	CcSEcCtD
Alendronate—Rash—Leflunomide—systemic scleroderma	0.000946	0.00118	CcSEcCtD
Alendronate—Dermatitis—Leflunomide—systemic scleroderma	0.000945	0.00118	CcSEcCtD
Alendronate—Nausea—Azathioprine—systemic scleroderma	0.000943	0.00118	CcSEcCtD
Alendronate—Headache—Leflunomide—systemic scleroderma	0.00094	0.00118	CcSEcCtD
Alendronate—Erythema—Prednisone—systemic scleroderma	0.000938	0.00117	CcSEcCtD
Alendronate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00093	0.00116	CcSEcCtD
Alendronate—Asthenia—Lisinopril—systemic scleroderma	0.000925	0.00116	CcSEcCtD
Alendronate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000923	0.00115	CcSEcCtD
Alendronate—Pruritus—Lisinopril—systemic scleroderma	0.000912	0.00114	CcSEcCtD
Alendronate—Vomiting—Mycophenolic acid—systemic scleroderma	0.00091	0.00114	CcSEcCtD
Alendronate—Haemoglobin—Methotrexate—systemic scleroderma	0.000905	0.00113	CcSEcCtD
Alendronate—Rash—Mycophenolic acid—systemic scleroderma	0.000902	0.00113	CcSEcCtD
Alendronate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000901	0.00113	CcSEcCtD
Alendronate—Haemorrhage—Methotrexate—systemic scleroderma	0.0009	0.00113	CcSEcCtD
Alendronate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000897	0.00112	CcSEcCtD
Alendronate—Headache—Mycophenolic acid—systemic scleroderma	0.000896	0.00112	CcSEcCtD
Alendronate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00112	CcSEcCtD
Alendronate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00112	CcSEcCtD
Alendronate—Nausea—Leflunomide—systemic scleroderma	0.000891	0.00111	CcSEcCtD
Alendronate—Diarrhoea—Lisinopril—systemic scleroderma	0.000882	0.0011	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisone—systemic scleroderma	0.00087	0.00109	CcSEcCtD
Alendronate—Anaemia—Prednisone—systemic scleroderma	0.000867	0.00108	CcSEcCtD
Alendronate—Angioedema—Prednisone—systemic scleroderma	0.000857	0.00107	CcSEcCtD
Alendronate—Dizziness—Lisinopril—systemic scleroderma	0.000852	0.00107	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000851	0.00106	CcSEcCtD
Alendronate—Nausea—Mycophenolic acid—systemic scleroderma	0.00085	0.00106	CcSEcCtD
Alendronate—Malaise—Prednisone—systemic scleroderma	0.000846	0.00106	CcSEcCtD
Alendronate—Vertigo—Prednisone—systemic scleroderma	0.000843	0.00105	CcSEcCtD
Alendronate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000832	0.00104	CcSEcCtD
Alendronate—Vomiting—Lisinopril—systemic scleroderma	0.000819	0.00102	CcSEcCtD
Alendronate—Rash—Lisinopril—systemic scleroderma	0.000813	0.00102	CcSEcCtD
Alendronate—Dermatitis—Lisinopril—systemic scleroderma	0.000812	0.00102	CcSEcCtD
Alendronate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00081	0.00101	CcSEcCtD
Alendronate—Headache—Lisinopril—systemic scleroderma	0.000807	0.00101	CcSEcCtD
Alendronate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000799	0.000999	CcSEcCtD
Alendronate—Myalgia—Prednisone—systemic scleroderma	0.000798	0.000999	CcSEcCtD
Alendronate—Alopecia—Methotrexate—systemic scleroderma	0.000796	0.000995	CcSEcCtD
Alendronate—Discomfort—Prednisone—systemic scleroderma	0.000789	0.000987	CcSEcCtD
Alendronate—Erythema—Methotrexate—systemic scleroderma	0.000784	0.00098	CcSEcCtD
Alendronate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000773	0.000966	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—systemic scleroderma	0.000767	0.00096	CcSEcCtD
Alendronate—Nausea—Lisinopril—systemic scleroderma	0.000765	0.000958	CcSEcCtD
Alendronate—Infection—Prednisone—systemic scleroderma	0.00076	0.000951	CcSEcCtD
Alendronate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000747	0.000934	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000727	0.00091	CcSEcCtD
Alendronate—Anaemia—Methotrexate—systemic scleroderma	0.000724	0.000906	CcSEcCtD
Alendronate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000718	0.000898	CcSEcCtD
Alendronate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000712	0.000891	CcSEcCtD
Alendronate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000711	0.00089	CcSEcCtD
Alendronate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000707	0.000885	CcSEcCtD
Alendronate—Malaise—Methotrexate—systemic scleroderma	0.000707	0.000884	CcSEcCtD
Alendronate—Vertigo—Methotrexate—systemic scleroderma	0.000704	0.000881	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000697	0.000872	CcSEcCtD
Alendronate—Dyspepsia—Prednisone—systemic scleroderma	0.000674	0.000843	CcSEcCtD
Alendronate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000671	0.000839	CcSEcCtD
Alendronate—Chest pain—Methotrexate—systemic scleroderma	0.000667	0.000835	CcSEcCtD
Alendronate—Myalgia—Methotrexate—systemic scleroderma	0.000667	0.000835	CcSEcCtD
Alendronate—Discomfort—Methotrexate—systemic scleroderma	0.000659	0.000825	CcSEcCtD
Alendronate—Constipation—Prednisone—systemic scleroderma	0.000654	0.000819	CcSEcCtD
Alendronate—Infection—Methotrexate—systemic scleroderma	0.000635	0.000795	CcSEcCtD
Alendronate—Feeling abnormal—Prednisone—systemic scleroderma	0.000631	0.000789	CcSEcCtD
Alendronate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000626	0.000783	CcSEcCtD
Alendronate—Urticaria—Prednisone—systemic scleroderma	0.000608	0.000761	CcSEcCtD
Alendronate—Abdominal pain—Prednisone—systemic scleroderma	0.000605	0.000757	CcSEcCtD
Alendronate—Body temperature increased—Prednisone—systemic scleroderma	0.000605	0.000757	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000583	0.000729	CcSEcCtD
Alendronate—Hypersensitivity—Prednisone—systemic scleroderma	0.000564	0.000705	CcSEcCtD
Alendronate—Dyspepsia—Methotrexate—systemic scleroderma	0.000563	0.000704	CcSEcCtD
Alendronate—Asthenia—Prednisone—systemic scleroderma	0.000549	0.000687	CcSEcCtD
Alendronate—Pain—Methotrexate—systemic scleroderma	0.000547	0.000684	CcSEcCtD
Alendronate—Pruritus—Prednisone—systemic scleroderma	0.000541	0.000677	CcSEcCtD
Alendronate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000527	0.000659	CcSEcCtD
Alendronate—Diarrhoea—Prednisone—systemic scleroderma	0.000524	0.000655	CcSEcCtD
Alendronate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000523	0.000654	CcSEcCtD
Alendronate—Urticaria—Methotrexate—systemic scleroderma	0.000508	0.000636	CcSEcCtD
Alendronate—Dizziness—Prednisone—systemic scleroderma	0.000506	0.000633	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—systemic scleroderma	0.000506	0.000633	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—systemic scleroderma	0.000506	0.000633	CcSEcCtD
Alendronate—Vomiting—Prednisone—systemic scleroderma	0.000487	0.000609	CcSEcCtD
Alendronate—Rash—Prednisone—systemic scleroderma	0.000483	0.000604	CcSEcCtD
Alendronate—Dermatitis—Prednisone—systemic scleroderma	0.000482	0.000603	CcSEcCtD
Alendronate—Headache—Prednisone—systemic scleroderma	0.000479	0.0006	CcSEcCtD
Alendronate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000471	0.000589	CcSEcCtD
Alendronate—Asthenia—Methotrexate—systemic scleroderma	0.000459	0.000574	CcSEcCtD
Alendronate—Nausea—Prednisone—systemic scleroderma	0.000455	0.000569	CcSEcCtD
Alendronate—Pruritus—Methotrexate—systemic scleroderma	0.000453	0.000566	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—systemic scleroderma	0.000438	0.000547	CcSEcCtD
Alendronate—Dizziness—Methotrexate—systemic scleroderma	0.000423	0.000529	CcSEcCtD
Alendronate—Vomiting—Methotrexate—systemic scleroderma	0.000407	0.000509	CcSEcCtD
Alendronate—Rash—Methotrexate—systemic scleroderma	0.000403	0.000504	CcSEcCtD
Alendronate—Dermatitis—Methotrexate—systemic scleroderma	0.000403	0.000504	CcSEcCtD
Alendronate—Headache—Methotrexate—systemic scleroderma	0.000401	0.000501	CcSEcCtD
Alendronate—Nausea—Methotrexate—systemic scleroderma	0.00038	0.000475	CcSEcCtD
